FINANCIALS

AYTU Aytu Biopharma Inc 1385818

Income Statement
Revenue	aytu20240930_10q	16,574,000
Net Income	aytu20240930_10q	1,474,000
Profit Margin		8.89%

Balance Sheet
Current Assets	71,130,000
Assets	115,831,000
Current Liabilities	61,252,000
Liabilities	86,005,000
Equity	29,826,000

Cash Flow Statement
Operating Cash Flow	-1,190,000
Investing Cash Flow	381,000

Market Analysis
Price	1.72
BVPS	5.52
PB	0.31
PS	7.66
FCF	-809,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view AYTU documents filed with the SEC.

AYTU Filings Clear

View A List of Tickers